BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8685092)

  • 1. [Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register].
    Welkerling H; Werner M; Delling G
    Pathologe; 1996 Jan; 17(1):18-25. PubMed ID: 8685092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathomorphology of malignant chondrogenic bone tumors--an analysis of 94 cases from the Hamburg Bone Tumor Register (1974-1989)].
    Delling G; Welkerling H
    Z Orthop Ihre Grenzgeb; 1992; 130(1):1-8. PubMed ID: 1532267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
    Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
    Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?
    Roitman PD; Farfalli GL; Ayerza MA; Múscolo DL; Milano FE; Aponte-Tinao LA
    Clin Orthop Relat Res; 2017 Mar; 475(3):808-814. PubMed ID: 26883651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data.
    Welkerling H; Kratz S; Ewerbeck V; Delling G
    Virchows Arch; 2003 Dec; 443(6):725-33. PubMed ID: 14513378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.
    Aigner T
    Virchows Arch; 2002 Sep; 441(3):219-30. PubMed ID: 12242518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological typing of chondrosarcoma: a study of 94 cases.
    Welkerling H; Dreyer T; Delling G
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):419-25. PubMed ID: 2035255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas.
    Dijkhuizen T; van den Berg E; Molenaar WM; Oosterhuis JW; Dam A; Wiersema J; Schraffordt Koops H; de Jong B
    Cancer Genet Cytogenet; 1994 Sep; 76(2):100-5. PubMed ID: 7923056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
    Anract P; Tomeno B; Forest M
    Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence analysis in 66 cases with grade I and grade II chondrosarcomas in the extremities.
    Ma XJ; Dong Y; Zhang CL; Zeng BF
    Orthop Surg; 2009 May; 1(2):132-6. PubMed ID: 22009830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional vs. extralesional procedures for low-grade central chondrosarcoma: a systematic review of the literature.
    Zoccali C; Baldi J; Attala D; Rossi B; Anelli V; Annovazzi A; Ferraresi V
    Arch Orthop Trauma Surg; 2018 Jul; 138(7):929-937. PubMed ID: 29633075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
    Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
    Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grade 2 chondrosarcoma: stage I or stage II tumor?
    Reith JD; Horodyski MB; Scarborough MT
    Clin Orthop Relat Res; 2003 Oct; (415):45-51. PubMed ID: 14612628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedifferentiated chondrosarcoma of bone with prominent rhabdoid component.
    Stemm M; Beck C; Mannem R; Neilson J; Klein MJ
    Ann Diagn Pathol; 2017 Jun; 28():7-11. PubMed ID: 28648942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
    Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
    J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of bone tumors.
    Bertoni F; Bacchini P
    Eur J Radiol; 1998 May; 27 Suppl 1():S74-6. PubMed ID: 9652505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
    Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
    Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
    Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic Resonance Imaging-Based Grading of Cartilaginous Bone Tumors: Added Value of Quantitative Texture Analysis.
    Fritz B; Müller DA; Sutter R; Wurnig MC; Wagner MW; Pfirrmann CWA; Fischer MA
    Invest Radiol; 2018 Nov; 53(11):663-672. PubMed ID: 29863601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.